Business Context and Reporting Period
Company: Kimberly-Clark Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: The Corporation operates in three primary segments: Personal Care (diapers, feminine care), Consumer Tissue (facial/bathroom tissue, paper towels), and Business-to-Business (away-from-home products, health care). The quarter included the consolidation of Kimberly-Clark Australia Pty. Limited ("KCA") and the adoption of new accounting standards (EITF 01-9 and SFAS 142).
Key Financial Metrics
| Metric (Millions, except per share) | Q1 2002 | Q1 2001 |
|---|---|---|
| Net Sales | $3,330.9 | $3,323.2 |
| Gross Profit | $1,212.4 | $1,170.7 |
| Operating Profit | $664.9 | $631.1 |
| Net Income | $439.2 | $433.4 |
| Diluted EPS | $0.84 | $0.81 |
| Cash Provided by Operations | $521.1 | $457.6 |
| Cash and Equivalents (End of Period) | $359.7 | $405.2 |
| Total Debt (Short + Long Term) | $3,592.8 | $3,660.1 |
Note: Total Debt calculated as Debt payable within one year ($776.3M) plus Long-term debt ($2,816.5M) for 2002.
Material Changes vs. Prior Period
- Revenue: Net sales increased slightly (0.2%) to $3.33 billion. Excluding currency effects, sales rose over 2% driven by volume growth in North America and the consolidation of KCA. Competitive pricing and promotions reduced sales by approximately 2%.
- Profitability: Operating profit increased 5.4% to $664.9 million. This was aided by the discontinuation of goodwill amortization (SFAS 142) and lower fiber/energy costs (~$80 million). However, higher advertising/promotion costs and pension expenses offset some gains.
- Segment Performance:
- Personal Care: Sales flat; volumes up 6% but prices down 2% due to competition.
- Consumer Tissue: Sales up 1.9%; volumes up nearly 5%.
- Business-to-Business: Sales down 3.3%; volumes up 2% but prices down 4%.
- Accounting Changes: Adoption of EITF 01-9 reclassified promotional costs as a reduction in revenue. Adoption of SFAS 142 eliminated goodwill amortization, resulting in a $21.8 million benefit in 2001 comparisons (no amortization in 2002).
Guidance, Outlook, and Risks
- Outlook: Management expects continued intense competition, particularly in diapers and training pants in North America and Europe. Economic conditions in Argentina and Brazil remain uncertain. The company anticipates benefits from the recovery of business-to-business operations in North America.
- Capital Strategy: The company raised its target range for the ratio of net debt and preferred securities to capital to 35-45% (previously 30-40%). At March 31, 2002, this ratio was 38.4%.
- Acquisitions: Amcor Limited intends to sell its remaining 45% interest in KCA to Kimberly-Clark for approximately $375 million, expected to close in June 2002.
- Risks & Contingencies:
- Legal: Ongoing asbestos litigation (approx. 267 lawsuits) and MESC arbitration (settled for $675,000). Management does not expect a material adverse effect.
- Environmental: Named as a potentially responsible party at various waste sites; no material adverse effect expected.
- Goodwill Impairment: Impairment testing for goodwill is ongoing and expected to be completed by June 30, 2002. Management does not expect write-offs.
Investor Verification Checklist
- Goodwill Impairment Testing: Verify the results of the SFAS 142 goodwill impairment testing expected by June 30, 2002, to ensure no unexpected write-offs.
- KCA Acquisition Closing: Confirm the closing of the remaining 45% KCA acquisition and the final purchase price.
- Promotional Spend Impact: Monitor the sustainability of operating margins given the "stepped-up" advertising and promotion levels required to counter competition.
- Latin America Performance: Track the recovery of sales volumes in Argentina and Brazil, which remain a source of uncertainty.
- Debt Maturity Profile: Review the impact of recent debt issuances ($800 million in notes) on future interest obligations and liquidity.